Cite

HARVARD Citation

    Valcárcel, D. et al. (2015). Use of newer prognostic indices for patients with myelodysplastic syndromes in the low and intermediate-1 risk categories: a population-based study. Lancet. 2 (6), pp. e260-e266. [Online]. 
  
Back to record